openPR Logo
Press release

Uterine Fibroids Pipeline Assessment growing over the forecast years 2019-2025

02-20-2019 01:52 PM CET | Health & Medicine

Press release from: Precision Business Insights

Uterine Fibroids Pipeline Assessment

Uterine Fibroids Pipeline Assessment

Uterine Fibroids Pipeline Assessment is Rising due to High investments for the R&D Activities
Analyst Speak:

“The Uterine Fibroids Pipeline Assessment growing over the forecast years 2019-2025 owing to grow in R&D activities by the market players”

The uterine fibroids pipeline assessment increasing over the forecast years due to surge in the prevalence of uterine fibroid cases in female coupled with increase in the R&D activities for the development of newer drugs by the various pharmaceutical and biopharmaceutical companies. Moreover, patent expiries of block buster drugs, and fund raising public and private sectors for the development R&D activities are propel the uterine fibroids pipeline assessment over the forecast years. However, stringent regulatory guidelines, high R&D cost for the development of newer therapeutics and adverse effects with the newer therapeutics, hinder the uterine fibroids pipeline assessment over the forecast timeframe

Uterine Fibroids Pipeline Assessment market segmented on the basis of clinical phase, route of administration, and region. Based on clinical phase, uterine fibroid drugs are segmented into Phase I, Phase II, Phase III, and Phase IV therapeutics. Based on the route of administration, the market is segmented into oral, vaginal, and others.

A sample of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/uterine-fibroids-pipeline-drugs-assessment/#ulp-4H8Z4LpNMLEuOnnx

Most of the companies are present in the Phase III clinical trials with positive efficacy and safety results in the treatment of uterine fibroid treatment. For instance, In October 2017, Takeda Pharmaceuticals partnered with Myovant and announced the positive Phase III clinical studies results in the development of Relugolix, a uterine fibroid treatment drug. Moreover, AbbVie, Inc. and Neurocrine Biosciences collaborated in the development of uterine fibroid treatment drug Elagolix and announced the second positive Phase III clinical trial studies in March 2018.

To view TOC of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/uterine-fibroids-pipeline-drugs-assessment/#ulp-c654SbFYO64MsOhu

Key player’s profiles in the report are Repros Therapeutics Inc. (U.S.), Bayer AG (Germany), Takeda Pharmaceutical Company Ltd (Japan), AbbVie Inc. (U.S.), KISSEI PHARMACEUTICAL CO.,Ltd. (Japan), BioSpecifics Technologies Corporation (U.S.), and DONGKOOK Pharmaceutical Co., Ltd (Japan)

Precision Business Insights (PBI) in its report titled “Uterine Fibroids Pipeline Assessment”: Clinical Trails Analysis, Collaborations, Key Targets, Geographic Focus, and Data Publications, Competitor Analysis 2018. The report also covers therapeutics under Development by Companies/Institutes/Universities, the molecules in Pre-Registration, Filing rejected/withdrawn, Phase I, Phase II, Phase III, IND/CTA Filed, Preclinical, and Discovery

Need more information about this report @
https://www.precisionbusinessinsights.com/market-reports/uterine-fibroids-pipeline-drugs-assessment/#ulp-14mlyhjMGhVjZqa3

Detailed Segmentation

By Clinical Trial Phase
o Pre-clinical phase
o Phase-I
o Phase II
o Phase-III
By Route of Administration
o Oral
o Vaginal
o Others
Geography
o North America
• U.S
• Canada
o Europe
• Germany
• France
• U.K
• Italy
• Spain
• Russia
• Poland
• Rest of Europe
o Asia-Pacific
• Japan
• China
• India
• Australia & New Zealand
• ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
• South Korea
• Rest of Asia-Pacific
o Latin America
• Brazil
• Mexico
• Argentina
• Venezuela
• Rest of Latin America
o Middle East and Africa (MEA)
• Gulf Cooperation Council (GCC) Countries
• Israel
• South Africa
• Rest of MEA

Get access to full summary @
https://www.precisionbusinessinsights.com/market-reports/uterine-fibroids-pipeline-drugs-assessment/

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,
152 – 160 City Road,
London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US): +1-866-598-1553
Website @ https://www.precisionbusinessinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Uterine Fibroids Pipeline Assessment growing over the forecast years 2019-2025 here

News-ID: 1603789 • Views:

More Releases from Precision Business Insights

Biochar Market Growth Is Attributed To The Increased Production Of Biochar Through Pyrolysis Technology
Biochar Market Growth Is Attributed To The Increased Production Of Biochar Throu …
According to Precision Business Insights (PBI), the latest report biochar market was valued at USD 243.8 million in 2022, growing at a 12.6% CAGR during the forecast period 2023 to 2029. The rising demand for organic and eco-friendly products drives the biochar market. Utilizing biochar corresponds with organic farming methods, improving market prospects. Furthermore, biochar is a potential material for water treatment and remediation because of its capacity to absorb
Vapor Recovery Units Market Growth Is Attributed To The Increased Adoption Of Membrane Separation Technology
Vapor Recovery Units Market Growth Is Attributed To The Increased Adoption Of Me …
According to Precision Business Insights (PBI), latest report vapor recovery units market was valued at USD 923.7 million in 2022 and is poised to grow at a CAGR of 4.2% during the forecast period 2023 to 2029. The adoption of stringent environmental regulations by governments and international bodies to reduce air pollution and greenhouse gas emissions in various countries drives the demand for the vapor recovery unit's market. Furthermore, the
Pyrite Market Growth Is Attributed To The Increased Demand In Jewelry Industry
Pyrite Market Growth Is Attributed To The Increased Demand In Jewelry Industry
According to Precision Business Insights (PBI), latest report pyrite market is growing at 4.9% CAGR during the forecast period 2023 to 2029. The increased application of pyrite in the manufacturing of sulfuric acid drives the pyrite market. The increase of prices of gold has led to increased demand for imitation jewelry which is anticipated to propel the pyrite market growth. Furthermore, the demand for sulphuric acid in a variety of
Industrial Boilers Market Growth Is Attributed To The Increased Use In Power Generation
Industrial Boilers Market Growth Is Attributed To The Increased Use In Power Gen …
According to Precision Business Insights (PBI), the latest report industrial boilers market size was valued at USD 15,261.8 million in 2022 and is poised to grow at a 3.1% CAGR during the forecast period 2023 to 2029. The adoption of stringent environmental regulations to maintain emission standards and carbon reduction in several countries drives the industrial boilers market. Furthermore, the advancement in boiler technology, such as better combustion systems, greater

All 5 Releases


More Releases for Phase

PanAfGeo: The Second Phase Begins!
The PanAfGeo community is pleased to announce the launching of the PanAfGeo second phase (PanAfGeo-2), which will continue to build on the first phase project’s achievements over the next three years. PanAfGeo, an EU co-funded initiative that began in 2016, contributed to the transfer of knowledge between European and African Geological Surveys. PanAfGeo also ensured the institutional strengthening of many African national administrations in charge of geology and mining. With the backing
COVID-19 - Pipeline Analysis 2020 for Global Market | Emphasis on Products cover …
COVID-19 (also known as Anderson COVID-19)?is a viral disease caused by RNA virus, SARS-CoV-2 or commonly known as corona virus. These viruses can cause respiratory, enteric, hepatic, and neurologic diseases. At the end of 2019, a new coronavirus was identified as the cause of a cluster of pneumonia cases in Wuhan, China. It rapidly spread, resulting in an epidemic throughout China, followed by an increasing number of cases in other
Power Metering Market Information by type (smart, digital, analog), by phase (si …
Power Metering Market Information by type (smart, digital, analog), by phase (single phase, three phase) by application (residential, commercial and industrial) and Region - Forecast to 2022 The report for Global Power Metering Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and
HIV Vaccines Market Perceive Aggrandized Growth at a CAGR of 11.48% Till 2023 | …
HIV Vaccines Market Report Added on MarketResearchFuture.com with Overall Analysis. Key developments and Strategies Cover in this Report. The Market for Expected to Grow Globally Over the CAGR of 5 % During the Period 2018 to 2027 from USD 2,702.3 Billion in 2027. HIV Vaccines Market - Segmentation The global HIV vaccines market has been segmented on the basis of basis of antibiotics, type, and lastly, region. Antibiotics have been segmented into dicloxacillin,
2026 Global Pharmacovigilance Market Growth Analysis by Clinical Trials Like Pre …
Global Pharmacovigilance Market 2018 report includes extensive Market analysis and industry landscape along with SWOT analysis and PESTEL analysis of the important vendors. The analysis is conducted with a blend of secondary and primary advice for inputs from participants in the industry. Pharmacovigilance industry report covers the prospects of Women’S Health P oducts in the forecast period of 2018-2026 and the scenario. Growing prevalence of adverse reactions caused by drugs, has
MAAT Inaugurates Versatile Phase Shifter
Company announces release of a digital recreation of Roger Schult’s analog hardware MAAT Incorporated, a manufacturer of exceptional performance professional audio solutions, today announced the release of RSPhaseShifter version 1.0, a digital implementation of the Roger Schult/German Audio Lab’s Phase Shifter 500 Series W2324 hardware. The cross–platform plug–in creates a high quality, phase shifted version of a monaural or stereo input. Available in formats for all major DAWs (Digital Audio Workstations), RSPhaseShifter